Advertisement
U.S. markets open in 2 hours 40 minutes
  • S&P Futures

    5,206.75
    -8.00 (-0.15%)
     
  • Dow Futures

    39,193.00
    -30.00 (-0.08%)
     
  • Nasdaq Futures

    18,192.50
    -39.00 (-0.21%)
     
  • Russell 2000 Futures

    2,047.00
    -2.80 (-0.14%)
     
  • Crude Oil

    82.57
    -0.15 (-0.18%)
     
  • Gold

    2,157.30
    -7.00 (-0.32%)
     
  • Silver

    25.10
    -0.16 (-0.63%)
     
  • EUR/USD

    1.0847
    -0.0029 (-0.27%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.58
    +0.25 (+1.74%)
     
  • GBP/USD

    1.2682
    -0.0046 (-0.36%)
     
  • USD/JPY

    150.5390
    +1.4410 (+0.97%)
     
  • Bitcoin USD

    63,121.58
    -4,795.43 (-7.06%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,711.09
    -11.46 (-0.15%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

What's in the Cards for DXC Technology's (DXC) Q1 Earnings?

DXC Technology Company DXC is set to release first-quarter fiscal 2021 results on Aug 6.

The Zacks Consensus Estimate for quarterly revenues is pinned at $4.24 billion, calling for a 13.4% year-over-year decline. The consensus mark for earnings is 11 cents per share, suggesting a 93.7% slump.

The company’s earnings outpaced estimates in three of the trailing four quarters and missed in the other, the average beat being 9.3%.

Let’s see how things have shaped up for the upcoming announcement.

DXC Technology Company. Price and Consensus

DXC Technology Company. price-consensus-chart | DXC Technology Company. Quote

Factors at Play

DXC’s fiscal first-quarter performance is likely to have been affected by the pandemic-induced business disruptions. Soft IT spending as organizations are pushing back their investments in big and expensive technology products, due to the global economic slowdown concerns amid the coronavirus crisis, might have hurt the company’s performance during the quarter to be reported.

Also, during the fourth-quarter fiscal 2020 earnings call, the company had stated that it anticipates revenue loss due to price concessions and terminated businesses to continue in first-quarter fiscal 2021. As a result, the company forecasts an 8-10% sequential decline in the fiscal first-quarter revenues.

Moreover, a weak traditional business is likely to have negatively impacted the top line during the quarter under review.

Furthermore, increased investments in the business and higher interest expenses are expected to have weighed on the company’s quarterly performance.

What Our Model Says

Our proven model does not predict an earnings beat for DXC this season. The combination of a positive Earnings ESP, and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the chances of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell, before they’re reported, with our Earnings ESP Filter.

DXC carries a Zacks Rank of 4 (Sell) and has an Earnings ESP of 0.00%, at present.

Stocks With Favorable Combinations

Here are some companies, which, per our model, have the right combinations of elements to post an earnings beat this quarter:

Cogent Communications Holdings CCOI has an Earnings ESP of +11.66% and carries a Zacks Rank of 2, at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Synaptics SYNA has an Earnings ESP of +10.6 % and currently carries a Zacks Rank of 2.

Benefitfocus BNFT has an Earnings ESP of +6.25% and carries a Zacks Rank of 2, currently.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Synaptics Incorporated (SYNA) : Free Stock Analysis Report
 
Cogent Communications Holdings, Inc. (CCOI) : Free Stock Analysis Report
 
Benefitfocus, Inc. (BNFT) : Free Stock Analysis Report
 
DXC Technology Company. (DXC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Advertisement